Literature DB >> 9552071

Oncologists' recognition of depression in their patients with cancer.

S D Passik1, W Dugan, M V McDonald, B Rosenfeld, D E Theobald, S Edgerton.   

Abstract

PURPOSE: This study was performed as part of a large depression screening project in cancer patients to determine the degree of physician recognition of levels of depressive symptoms in cancer patients and to describe patient characteristics that influence the accuracy of physician perception of depressive symptoms.
METHODS: Twenty-five ambulatory oncology clinics affiliated with Community Cancer Care, Inc of Indiana enrolled and surveyed 1,109 subjects treated by 12 oncologists. Subjects completed the Zung Self-Rating Depression Scale (ZSDS) and physicians were asked to rate their patients' level of depressive symptoms, anxiety, and pain using numerical rating scales. Subjects' sex, age, primary tumor type, medications, primary caregiver, and disease stage at diagnosis were also recorded.
RESULTS: Physician ratings of depression were significantly associated with their patients' levels of endorsement of depressive symptoms on the ZSDS. However, agreement between physicians and patients is most frequently clustered when patients report little or no depressive symptoms. While physician ratings are concordant with patient endorsement of no significant depressive symptomatology 79% of the time, they are only concordant 33% and 13% of the time in the mild-to-moderate/severe ranges, respectively. Physician ratings were most influenced by patient endorsement of frequent and obvious mood symptoms, ie, sadness, crying, and irritability. Physician ratings also appeared to be influenced by medical correlates of patients' level of depressive symptoms (functional status, stage of disease, and site of tumor). Additionally, patients whose depression was inaccurately classified reported significantly higher levels of pain and had higher levels of disability. Physicians' ratings of depression were most highly correlated with physicians' ratings of patients' anxiety and pain.
CONCLUSION: Physicians' perceptions of depressive symptoms in their patients are correlated with patient's ratings, but there is a marked tendency to underestimate the level of depressive symptoms in patients who are more depressed. They are most influenced by symptoms such as crying and depressed mood, and medical factors that are useful, but not the most reliable, indicators of depression in this population. Physicians' ratings of their patients' distress symptoms seem to be global in nature--they are highly correlated with anxiety, pain, and global dysfunction. Physician assessment might be improved if they were instructed to assess and probe for the more reliable cognitive symptoms such as anhedonia, guilt, suicidal thinking, and hopelessness. Screening instruments and the use of brief follow-up interviews would help to identify patients who are depressed.

Entities:  

Mesh:

Year:  1998        PMID: 9552071     DOI: 10.1200/JCO.1998.16.4.1594

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  130 in total

1.  Fatigue in cancer.

Authors:  G A Curt
Journal:  BMJ       Date:  2001-06-30

Review 2.  Effect of sex and gender on psychosocial aspects of prostate and breast cancer.

Authors:  A Kiss; S Meryn
Journal:  BMJ       Date:  2001-11-03

3.  The role of trait emotional intelligence in the diagnostic cancer pathway.

Authors:  Samuel G Smith; K V Petrides; James S A Green; Nick Sevdalis
Journal:  Support Care Cancer       Date:  2012-03-09       Impact factor: 3.603

4.  Oncologists' assessments of lung cancer patient and family disagreements regarding treatment decision making.

Authors:  Laura A Siminoff; Lindsey Dorflinger; Amma Agyemang; Sherman Baker; Maureen Wilson-Genderson
Journal:  Lung Cancer       Date:  2012-03-08       Impact factor: 5.705

5.  Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians.

Authors:  Laura P Forsythe; Catherine M Alfano; Corinne R Leach; Patricia A Ganz; Michael E Stefanek; Julia H Rowland
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

Review 6.  Advances in quality of life research among head and neck cancer patients.

Authors:  Allen C Sherman; Stephanie Simonton
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

7.  Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System.

Authors:  Devon K Check; Marilyn L Kwan; Neetu Chawla; Stacie B Dusetzina; Emily Valice; Isaac J Ergas; Janise M Roh; Tatjana Kolevska; Donald L Rosenstein; Lawrence H Kushi
Journal:  J Pain Symptom Manage       Date:  2018-12-01       Impact factor: 3.612

8.  Integrating mental health screening and abnormal cancer screening follow-up: an intervention to reach low-income women.

Authors:  Kathleen Ell; Betsy Vourlekis; Jan Nissly; Deborah Padgett; Diana Pineda; Olga Sarabia; Virginia Walther; Susan Blumenfield; Pey-jiuan Lee
Journal:  Community Ment Health J       Date:  2002-08

9.  Clinic-based depression screening in lung cancer patients using the PHQ-2 and PHQ-9 depression questionnaires: a pilot study.

Authors:  J Michael Randall; Rochelle Voth; Erin Burnett; Lyudmila Bazhenova; Wayne A Bardwell
Journal:  Support Care Cancer       Date:  2013-01-17       Impact factor: 3.603

10.  Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer.

Authors:  Jesse R Fann; Donna L Berry; Seth Wolpin; Mary Austin-Seymour; Nigel Bush; Barbara Halpenny; William B Lober; Ruth McCorkle
Journal:  Psychooncology       Date:  2009-01       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.